Showing results (1071-1080 of 1,468) with videos related to

Sort By:
Pageof 147
Transplantation|June 29, 2011
Addition of a water-soluble propofol formulation to preservation solution in experimental kidney transplantationMaarten G J Snoeijs, Lauri Vaahtera, Eva E de Vries, et al.
International Journal of Oncology|October 9, 2003
Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumoursG Bea A Wisman, Harry Hollema, Marco N Helder, et al.
British Journal of Pharmacology|August 4, 2004
Preclinical characterisation of 111In-DTPA-trastuzumabMarjolijn N Lub-de Hooge, Jos G W Kosterink, Patrick J Perik, et al.
Fluids and Barriers of the CNS|December 15, 2021
Modeling ischemic stroke in a triculture neurovascular unit on-a-chipNienke R Wevers, Arya Lekshmi Nair, Tania M Fowke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Human Epidermal Growth Factor Receptor 3-Specific Tumor Uptake and Biodistribution of 89Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET ImagingFrank J Warnders, Anton G T Terwisscha van Scheltinga, Christine Knuehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I studyConstantijne H Mom, Jaap Verweij, Corina N A M Oldenhuis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2012
PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemmaMichel van Kruchten, Andor W J M Glaudemans, Erik F J de Vries, et al.
Cancer Treatment Reviews|July 7, 2015
Rectal and colon cancer: Not just a different anatomic siteK Tamas, A M E Walenkamp, E G E de Vries, et al.
International Journal of Cancer|June 21, 2008
A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explantsBrigitte M T Hougardy, Nathalie Reesink-Peters, Fiona A J van den Heuvel, et al.
Pageof 147